Moving average template subtraction to remove stimulation artefacts in EEGs and LFPs recorded during deep brain stimulation
L Sun, H Hinrichs - Journal of Neuroscience Methods, 2016 - Elsevier
Background Deep brain stimulation (DBS) is a well established therapy to treat movement
disorders such as Parkinson's disease. More recently it has also been discussed as a …
disorders such as Parkinson's disease. More recently it has also been discussed as a …
[HTML][HTML] L'origine della depressione nella malattia di Alzheimer: una revisione della letteratura
MC Quattropani, V Lenzo, V Armieri… - Rivista di …, 2018 - rivistadipsichiatria.it
Scopo. I disturbi depressivi sono stati associati alla malattia di Alzheimer (AD), ma il loro
ruolo come possibile sintomo predittivo, fattore di rischio o reattivo non è ancora stato …
ruolo come possibile sintomo predittivo, fattore di rischio o reattivo non è ancora stato …
Design and Fabrication of Novel Digital Transcranial Electrical Stimulator for Medical and Psychiatry Applications
HA Jafari, MB Heydari, N Jafari… - arXiv preprint arXiv …, 2020 - arxiv.org
In this article, we design a novel Transcranial Electrical Stimulator for medical applications,
which is very cheap and can produce the desired signals very accurately. Our fabricated …
which is very cheap and can produce the desired signals very accurately. Our fabricated …
A unique case of very low‐dose subcutaneous ketamine use: Maintenance option of ketamine for treatment‐resistant depression
AT Can, DF Hermens, J Lagopoulos - Clinical case reports, 2022 - Wiley Online Library
Numerous studies have demonstrated that low‐dose subanesthetic intravenous ketamine
infusion treatment leads to rapid improvement of treatment‐resistant depression. The …
infusion treatment leads to rapid improvement of treatment‐resistant depression. The …